MDS Nordion of Kanata, Ontario, reported last month that it will enlarge its operations in a $12.3 million expansion that will include a 48,000-sq-ft building with space for radiopharmaceutical production, laboratories, packaging, shipping, and
MDS Nordion of Kanata, Ontario, reported last month that it will enlarge its operations in a $12.3 million expansion that will include a 48,000-sq-ft building with space for radiopharmaceutical production, laboratories, packaging, shipping, and warehousing. The company also plans to expand its cobalt-60 production facility by 5000 sq ft. The project will be complete by August 1999, according to the Canadian radiopharmaceutical firm. In addition to cobalt-60, MDS Nordion processes and distributes molybdenum that it receives from Atomic Energy of Canada (AECL).
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.